tradingkey.logo

Prestige Consumer Healthcare Inc

PBH
62.855USD
+0.435+0.70%
收盤 12/26, 16:00美東報價延遲15分鐘
3.02B總市值
15.48本益比TTM

Prestige Consumer Healthcare Inc

62.855
+0.435+0.70%

關於 Prestige Consumer Healthcare Inc 公司

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.

Prestige Consumer Healthcare Inc簡介

公司代碼PBH
公司名稱Prestige Consumer Healthcare Inc
上市日期Feb 10, 2005
CEOLombardi (Ronald M)
員工數量600
證券類型Ordinary Share
年結日Feb 10
公司地址660 White Plains Rd.
城市TARRYTOWN
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編10591
電話19145246800
網址https://www.prestigebrands.com/
公司代碼PBH
上市日期Feb 10, 2005
CEOLombardi (Ronald M)

Prestige Consumer Healthcare Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
49.39K
-5.73%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
34.20K
-0.81%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-30.95%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
14.33K
+17.11%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
11.33K
+22.68%
Mr. James C. D'arecca
Mr. James C. D'arecca
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
49.39K
-5.73%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
34.20K
-0.81%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.19%
The Vanguard Group, Inc.
11.40%
Ariel Investments, LLC
7.48%
Dimensional Fund Advisors, L.P.
5.39%
Kayne Anderson Rudnick Investment Management, LLC
4.60%
其他
56.93%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.19%
The Vanguard Group, Inc.
11.40%
Ariel Investments, LLC
7.48%
Dimensional Fund Advisors, L.P.
5.39%
Kayne Anderson Rudnick Investment Management, LLC
4.60%
其他
56.93%
股東類型
持股股東
佔比
Investment Advisor
70.09%
Investment Advisor/Hedge Fund
29.81%
Research Firm
3.29%
Hedge Fund
2.49%
Pension Fund
1.40%
Individual Investor
1.31%
Sovereign Wealth Fund
1.15%
Family Office
0.62%
Bank and Trust
0.55%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
667
52.11M
108.37%
-2.03M
2025Q2
667
53.74M
109.15%
-2.00M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
2023Q2
589
51.93M
104.86%
-4.95M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.03M
14.28%
-239.29K
-3.29%
Jun 30, 2025
The Vanguard Group, Inc.
5.62M
11.42%
-2.89K
-0.05%
Jun 30, 2025
Ariel Investments, LLC
2.20M
4.47%
-316.61K
-12.57%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.47M
5.02%
-244.43K
-9.00%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
1.75M
3.55%
+168.12K
+10.64%
Jun 30, 2025
State Street Investment Management (US)
2.00M
4.06%
+1.65K
+0.08%
Jun 30, 2025
Nomura Investment Management Business Trust
1.97M
4%
-285.27K
-12.66%
Jun 30, 2025
Allspring Global Investments, LLC
1.52M
3.09%
-94.00K
-5.82%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.41M
2.87%
+9.46K
+0.67%
Jun 30, 2025
Westwood Management Corp. (Texas)
881.91K
1.79%
+20.63K
+2.39%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco Pharmaceuticals ETF
2.44%
State Street SPDR S&P Pharmaceuticals ETF
2.43%
Schwab Ariel Opportunities ETF
2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.05%
Congress SMid Growth ETF
1.94%
Invesco S&P SmallCap Health Care ETF
1.83%
iShares U.S. Pharmaceuticals ETF
1.1%
Brandes US Small-Mid Cap Value ETF
0.84%
Invesco S&P SmallCap Low Volatility ETF
0.71%
JPMorgan Active Small Cap Value ETF
0.68%
查看更多
Invesco Pharmaceuticals ETF
佔比2.44%
State Street SPDR S&P Pharmaceuticals ETF
佔比2.43%
Schwab Ariel Opportunities ETF
佔比2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比2.05%
Congress SMid Growth ETF
佔比1.94%
Invesco S&P SmallCap Health Care ETF
佔比1.83%
iShares U.S. Pharmaceuticals ETF
佔比1.1%
Brandes US Small-Mid Cap Value ETF
佔比0.84%
Invesco S&P SmallCap Low Volatility ETF
佔比0.71%
JPMorgan Active Small Cap Value ETF
佔比0.68%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Prestige Consumer Healthcare Inc的前五大股東是誰?

Prestige Consumer Healthcare Inc的前五大股東如下:
BlackRock Institutional Trust Company, N.A.
持有股份:7.03M
佔總股份比例:14.28%。
The Vanguard Group, Inc.
持有股份:5.62M
佔總股份比例:11.42%。
Ariel Investments, LLC
持有股份:2.20M
佔總股份比例:4.47%。
Dimensional Fund Advisors, L.P.
持有股份:2.47M
佔總股份比例:5.02%。
Kayne Anderson Rudnick Investment Management, LLC
持有股份:1.75M
佔總股份比例:3.55%。

Prestige Consumer Healthcare Inc的前三大股東類型是什麼?

Prestige Consumer Healthcare Inc 的前三大股東類型分別是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Ariel Investments, LLC

有多少機構持有Prestige Consumer Healthcare Inc(PBH)的股份?

截至2025Q3,共有667家機構持有Prestige Consumer Healthcare Inc的股份,合計持有的股份價值約為52.11M,占公司總股份的108.37% 。與2025Q2相比,機構持股有所增加,增幅為-0.78%。

哪個業務部門對Prestige Consumer Healthcare Inc的收入貢獻最大?

在FY2025,--業務部門對Prestige Consumer Healthcare Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI